LAMISIL®


tablets
scheduling status
S4
registration number
Z/20.2.2/185
What LAMISIL® contains
Each 250 mg tablet contains 250 mg terbinafine as terbinafine hydrochloride.
other ingredients
Magnesium stearate; silica colloidal anhydrous; hydroxypropylmethyl cellulose; microcrystalline cellulose; sodium carboxymethyl starch.
Therapeutic classification
Pharmacotherapeutic group: A 20.2.2. Antimicrobial (Chemotherapeutic) agents. Fungicides.
© 2026 SAHPRA. ALL RIGHTS RESERVED